quinoxalines has been researched along with Sclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eilers, A; Gabriel, S; Heinemann, U; Jauch, R; Kivi, A; Kovács, R; Lehmann, TN; Meencke, HJ; von Deimling, A | 1 |
| Gabriel, S; Heinemann, U; Jauch, R; Lehmann, TN; Windmüller, O | 1 |
2 other study(ies) available for quinoxalines and Sclerosis
| Article | Year |
|---|---|
Effects of barium on stimulus-induced rises of [K+]o in human epileptic non-sclerotic and sclerotic hippocampal area CA1.
Topics: 2-Amino-5-phosphonovalerate; Adult; Barium Compounds; Bicuculline; Buffers; Chlorides; Electric Stimulation; Electrophysiology; Epilepsy, Temporal Lobe; Excitatory Amino Acid Antagonists; GABA Antagonists; Hippocampus; Humans; In Vitro Techniques; Potassium; Quinoxalines; Sclerosis; Synaptic Transmission | 2000 |
Effects of barium, furosemide, ouabaine and 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) on ionophoretically-induced changes in extracellular potassium concentration in hippocampal slices from rats and from patients with epilepsy.
Topics: 2-Amino-5-phosphonovalerate; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Anesthetics, Local; Animals; Barium; Buffers; Diuretics; Enzyme Inhibitors; Epilepsy; Excitatory Amino Acid Antagonists; Extracellular Space; Furosemide; Hippocampus; Humans; In Vitro Techniques; Iontophoresis; Ouabain; Potassium; Quaternary Ammonium Compounds; Quinoxalines; Rats; Rats, Wistar; Sclerosis; Tetrodotoxin | 2002 |